The study is notable less for its size than for its novelty. Until now, all evidence on this topic came from questionnaires and interviews rather than measured physiology. In one frequently cited survey of 53 young adults with type 1 diabetes, roughly one third reported fearing hypoglycaemia during sexual activity. But no one had ever tracked what actually happens to blood glucose in the hours surrounding sex. The Warsaw team set out to close that gap by combining real-time CGM data with participant-reported events, creating the first objective physiological picture of glucose dynamics during and after sexual intercourse in people with type 1 diabetes.

Dr Orłowska explained the clinical reasoning behind the research. On paper, sex is physical exertion like any other, and exertion lowers glucose. In practice, however, it behaves differently from planned exercise. A person preparing for a workout can reduce an insulin dose, eat carbohydrates beforehand, or activate an exercise mode on an insulin pump. Sexual activity, by contrast, is usually spontaneous, and it typically occurs in the evening or at night — precisely the window in which severe and unnoticed hypoglycaemia is most likely. Compounding the problem, she noted, is silence: patients routinely discuss exercise with their diabetologists and receive concrete advice, but almost nobody asks about sex, so the fear is never addressed. Yet sexual life is central to quality of life, and fear of hypoglycaemia can lead people to avoid intimacy entirely.

To investigate, the researchers enrolled 12 adults with type 1 diabetes — seven women and five men — in a prospective observational study. Participants had a median age of 36 years, ranging from 21 to 64, and a mean body mass index of 24 kg/m². All wore CGM devices, either the FreeStyle Libre 2 or the Guardian 4. Six were treated with multiple daily insulin injections and six with insulin pump therapy, including two using automated insulin delivery systems. None of the five male participants reported erectile dysfunction. Over a three-month period, participants marked each instance of sexual intercourse in their CGM application, allowing the researchers to analyse glucose data from two hours before to six hours after every event.

In total, 110 sexual intercourse events were recorded. A telling behavioural detail emerged: all participants using insulin pump therapy reported removing their devices during sex, meaning glucose readings during the events themselves came from the surrounding CGM trace rather than pump-integrated data. Despite the potential for exertion-related glucose drops, no clinically significant hypoglycaemia was observed anywhere in the dataset. Blood sugar changes were also unrelated to insulin therapy mode or to how long a participant had lived with diabetes, suggesting the response pattern is broadly consistent across treatment approaches.

The most striking finding was the bidirectionality of the glucose response. In 64 events, representing 58 percent of the total, mean post-intercourse glucose fell by 27 percent, from 180 to 132 mg/dL — a statistically significant decrease. In the remaining 46 events, or 42 percent, glucose rose by 34 percent, from 122 to 164 mg/dL, also statistically significant. Both increasing and decreasing patterns were observed within every single participant, meaning no individual could be classified as a consistent

The direction of the glucose response was not random. Higher glucose levels before intercourse were associated with a greater subsequent fall when glucose declined, and with a smaller rise when glucose increased, suggesting the body’s response may partly depend on the starting metabolic state. This bidirectional pattern echoes what is known about exercise physiology more broadly: physical activity typically lowers glucose by increasing muscle glucose uptake, but factors such as adrenaline, anticipatory stress, and circulating insulin levels can push glucose in the opposite direction. Sexual activity combines elements of exertion with emotional arousal, and the new data suggest these competing forces can net out in either direction in any given encounter.

Timing emerged as a meaningful variable. Of the 110 recorded events, 66 occurred at night, defined as between 20:00 and 06:00, and these nighttime events were associated with a statistically significant reduction in glucose levels, from a mean of 165 to 147 mg/dL. Daytime events, numbering 44, produced essentially no change, with mean glucose moving only from 144 to 143 mg/dL. The researchers also found no difference between mean glucose measured two hours after intercourse and six hours after, indicating that any glucose effects of sexual activity had largely settled within the first two hours rather than producing delayed drops hours later. That detail matters clinically, since delayed-onset hypoglycaemia is a well-recognised hazard after vigorous exercise and a common source of anxiety among people using insulin.

Body composition appeared to influence the response as well. Participants with a body mass index of 25 or higher showed a statistically significant post-intercourse glucose decrease of 10.7 percent, from 150 to 134 mg/dL, while those with a BMI under 25 showed a smaller, non-significant decline of 5.6 percent, from 159 to 150 mg/dL. The authors suggest this may reflect differences in energy expenditure, insulin sensitivity, or muscle mass, though the small sample size makes it impossible to draw firm conclusions. Diabetes duration, meanwhile, had no detectable effect on glucose responses, and neither did the mode of insulin delivery, whether multiple daily injections, conventional pump therapy, or automated insulin delivery.

The study’s limitations deserve emphasis. Twelve participants and 110 events are enough to generate hypotheses and provide reassurance, but not enough to establish definitive risk estimates for subgroups. All participants were adults in mid-life on average, with a normal mean BMI, and none of the men reported erectile dysfunction, so the findings may not extend to people with diabetes-related sexual dysfunction, older adults, or those with hypoglycaemia unawareness, a condition in which the normal warning symptoms of falling glucose are blunted. People with impaired awareness of hypoglycaemia are generally considered at higher risk during any unplanned activity, and clinicians may reasonably advise more cautious monitoring for them regardless of these results.

There is also the question of what the CGM trace can and cannot capture. Because every pump user removed their device during intercourse, the analysis relied on interstitial glucose readings from the surrounding period, and interstitial glucose lags behind blood glucose by several minutes to more than a quarter of an hour. Rapid changes during the event itself could therefore be somewhat smoothed or delayed in the recorded data. The researchers defined clinically significant hypoglycaemia according to standard thresholds used in diabetes research, and no readings crossed those thresholds, but the study was not powered to detect rare events. A single severe episode among hundreds of encounters would not necessarily appear in a dataset of this size.

Even with those caveats, the findings carry practical weight for clinical counselling. Diabetes care guidelines encourage clinicians to discuss the impact of physical activity on glucose, but sexual activity is rarely mentioned, and patients rarely raise it themselves. Dr Orłowska and her colleagues argue that the silence itself is harmful: fear of hypoglycaemia during sex can lead to avoidance of intimacy, strain on relationships, and reduced quality of life, all of which are recognised concerns in diabetes care yet seldom addressed in routine consultations. Objective evidence that intercourse does not typically provoke dangerous glucose lows gives clinicians a concrete, evidence-based starting point for those conversations.

The results also offer a framework for individualised advice rather than blanket reassurance. Because starting glucose level, time of day, and BMI all appeared to shape the glucose response, people with type 1 diabetes and their clinicians can use these factors when thinking about personal risk. Someone beginning sexual activity with a glucose level already trending low at night may reasonably choose to check a reading beforehand or keep fast-acting carbohydrates within reach, while someone starting from a higher glucose level may see little change or even a rise. The observation that glucose effects settled within two hours, with no delayed divergence at the six-hour mark, may further ease worries about overnight lows following evening intimacy.

The authors close with a reminder about technology access. In an ideal world, they note, every person with type 1 diabetes would use continuous glucose monitoring; those who do not may have no way of knowing whether they experience hypoglycaemia during sex or in any other setting. For the growing number of CGM users, however, the device itself offers a simple tool: marking events and reviewing the surrounding trace can turn an abstract fear into personal data. As the first study to measure glucose objectively in this context, the Warsaw work transforms a question that has lived only in surveys and unspoken anxieties into an answerable physiological one, and it opens the door to larger studies in more diverse populations.

Subject of Research: Glucose responses to sexual intercourse in adults with type 1 diabetes measured by continuous glucose monitoring

Article Title: Sex is safe in type 1 diabetes, shows small study using continuous glucose monitoring devices

Article References: Sex is safe in type 1 diabetes, shows small study using continuous glucose monitoring devices. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: type 1 diabetes, continuous glucose monitoring, hypoglycaemia, sexual intercourse, EASD, blood glucose, insulin therapy, quality of life, observational study, Medical University of Warsaw, nocturnal hypoglycaemia, diabetes counselling

The research team, led by scientists working with Arba Minch University and the International Centre for Agricultural Research in the Dry Areas, set out to address a striking gap in livestock science. Numerous studies have examined how individual feed ingredients affect goat physiology under laboratory conditions, but few have directly compared the haematological and biochemical profiles of animals raised in the two dominant production systems of the tropical world: extensive range grazing and indoor concentrate feeding. Nor have breeding bucks, the animals on which herd fertility ultimately depends, received much scientific attention compared with does, kids or fattening stock.

The stakes are considerable. Goats were among the first ungulates humans domesticated, and across tropical and subtropical regions they remain a cornerstone of food security where crop farming is difficult. Yet range-based systems depend on seasonal pastures increasingly battered by drought, erratic rainfall and heat stress. During dry periods, grazing animals routinely face protein and energy shortfalls, parasitic burdens and anti-nutritional plant compounds, producing chronic undernutrition that erodes both growth and immunity. Concentrate supplementation has been proposed as a practical buffer, but its systemic consequences inside the animal had never been fully mapped in this context.

To do so, the researchers recruited forty intact yearling bucks, averaging roughly 22 kilograms, from smallholder flocks enrolled in a community-based breeding programme in the Konso Zone. Each animal passed a veterinary examination and was dewormed before the trial began. Following a fifteen-day adaptation period, the bucks were assigned in a randomized complete block design to one of four groups of ten, blocked by body weight. The control group grazed natural pasture for roughly ten hours a day across twenty-five hectares of botanically diverse rangeland, rotated every five days. The three indoor groups were penned individually and fed mixed rations in which roughage and concentrate were balanced at 60:40, 50:50 and 40:60 on a dry matter basis.

The diets were formulated from locally harvested forages, including native grasses, tree foliage from Tremenalia brownie and Cordia africana, and maize and sorghum stovers, blended with a commercial concentrate containing maize grain, wheat bran, wheat middlings, noug cake, vitamin premix and salt. Laboratory analysis confirmed that crude protein climbed steadily from 7.05 percent in the range fodder to 15.00 percent in the highest-concentrate ration, while neutral detergent fibre fell from nearly 59 percent to about 30 percent. Animals were fed at 3 percent of metabolic body weight in two daily portions, and blood was drawn from every buck six times over the ninety-day trial, before the morning meal.

The haematological results were clear. Haemoglobin concentration, red blood cell count and packed cell volume were all significantly elevated in the bucks fed the two highest-concentrate rations compared with the grazing controls. Red cell counts rose from 8.52 million cells per microlitre in the grazing group to as high as 12.45 million in the 50:50 group, and packed cell volume climbed from about 23 percent to nearly 36 percent. All values remained within clinical reference ranges for healthy goats, indicating that the shift reflects enhanced erythropoiesis and oxygen-carrying capacity rather than pathology. The moderate 60:40 diet produced intermediate values that did not differ statistically from either extreme.

Equally informative were the parameters that did not move. Mean corpuscular volume, mean corpuscular haemoglobin, mean corpuscular haemoglobin concentration, white blood cell counts and red cell distribution widths were statistically indistinguishable across all four groups, and nearly all fell within accepted reference intervals. The authors note that white cell counts across all treatments ran above typical laboratory reference values, which they interpret as an active immunological response to environmental challenge rather than disease; crucially, no buck showed signs of inflammation, anaemia, haemolysis or toxicity. In other words, concentrate feeding amplified the oxygen-transport arm of the blood without disturbing its immune or cellular architecture.

The serum chemistry told a complementary story. Total protein, albumin and glucose were all significantly higher in the concentrate-fed animals, with total protein peaking at 8.95 grams per decilitre in the 50:50 group against 6.22 in the grazing controls. Albumin rose from 2.51 to as much as 3.87 grams per decilitre, and glucose climbed from 43.5 to as much as 56.25 milligrams per decilitre. The grazing bucks’ glucose values actually dipped below the normal range for healthy goats, which the authors attribute to the metabolic demands of walking long distances on the range and to environmental stress, effectively a state of mild hypoglycaemia. Meanwhile, liver enzymes, urea and creatinine remained unchanged and clinically normal in every group, indicating that neither feeding system imposed hepatic or renal strain.

Perhaps the most striking result concerned reproduction. Serum testosterone was significantly higher in all three concentrate-fed groups, peaking at 16.25 nanograms per millilitre in the 50:50 diet compared with 8.50 in the grazing animals. Testosterone also correlated strongly with serum protein, albumin and glucose, reinforcing the link between nutritional status and endocrine function. Because circulating testosterone underpins libido, spermatogenic activity and male fertility, the finding suggests that concentrate feeding could enhance breeding-buck performance through endocrine pathways. Consistent with this, serum calcium was elevated in the highest-concentrate group, a mineral vital for neuromuscular function, bone development and sperm maturation, while sodium, potassium, chloride and phosphorus remained stable and within healthy limits.

Correlation analysis added mechanistic texture to the picture. Red cell counts tracked tightly with haemoglobin and packed cell volume, confirming that the oxygen-transport gains reflect genuine increases in circulating red cells. Serum protein moved in lockstep with albumin and testosterone, and the near-perfect correlation between the two red cell distribution indices matched patterns reported for other goat breeds worldwide. For smallholder farmers confronting shrinking pastures and a changing climate, the practical message is that upgrading the diet of breeding bucks does more than fatten them: it measurably enriches their blood, steadies their metabolism and potentially strengthens the reproductive engine on which the entire flock depends. The study positions routine blood profiling as an accessible, powerful tool for designing feeding strategies that safeguard goat health where it matters most.

Subject of Research: The effects of range grazing versus indoor concentrate-based feeding systems on the haematological, biochemical and reproductive blood markers of goat bucks.

Article Title: The Haematological and Biochemical Responses of Goat Bucks to Range Grazing and Indoor Concentrate‐Based Feeding Systems

Article References: Abraham, S., Kechero, Y., & Wamatu, J. (2026). The Haematological and Biochemical Responses of Goat Bucks to Range Grazing and Indoor Concentrate‐Based Feeding Systems. Veterinary Medicine and Science, 12(5), Article e71221. https://doi.org/10.1002/vms3.71221

Image Credits: AI Generated

DOI: 10.1002/vms3.71221

Keywords: goat bucks, Woyto-Guji goats, concentrate feeding, range grazing, haematology, serum biochemistry, testosterone, blood glucose, Ethiopia, livestock nutrition, packed cell volume, animal health